This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2025 — Pharmaceutical Compliance Congress
Delivered as a Hybrid Event
April 28-30, 2025The Ritz-Carlton, Tysons Corner | McLean, VA

David Earl Smith
Executive Director, Ethics & Compliance at Eli Lilly
Speaker

Profile

David Earl has served in the pharmaceutical industry for over 30 years in a host of commercial and leadership roles. He has made contributions in multiple organizations including Sales, Marketing, Operations, Payer, and Global Market Research. He has served in Ethics & Compliance for the past 11 years where he has provided oversight to Oncology, Biomedicines, Patient Services, Medical Affairs, and the Grants Office functions. David Earl is actively involved with Business Ethics Indiana where he serves as VP of Administration. David Earl earned a B.S Degree from Tuskegee University, an MBA from Columbia University, and a Certification in Advance Topics in E&C Management from Marian University.

Agenda Sessions

  • Chief Compliance Officer Panel: Drivers for Change and Challenges for the Year Ahead

    8:50am